Literature DB >> 22499844

Hemodynamic changes in patients with arteriovenous malformations assessed using high-resolution 3D radial phase-contrast MR angiography.

W Chang1, M W Loecher, Y Wu, D B Niemann, B Ciske, B Aagaard-Kienitz, S Kecskemeti, K M Johnson, O Wieben, C Mistretta, P Turski.   

Abstract

BACKGROUND AND
PURPOSE: Arteriovenous malformations have a high lifetime risk of hemorrhage; however, treatment carries a significant risk of morbidity and mortality, including permanent neurologic sequelae. WSS and other hemodynamic parameters are altered in patients with symptomatic AVMs, and analysis of hemodynamics may have value in stratifying patients into different risk groups. In this study, we examined hemodynamic data from patients with stable symptoms and those who presented with acute symptoms to identify trends which may help in risk stratification.
MATERIALS AND METHODS: Phase-contrast MRA using a radial readout (PC-VIPR) is a fast, high-resolution technique that can acquire whole-brain velocity-encoded angiograms with scan times of approximately 5 minutes. Ten patients with AVMs were scanned using PC-VIPR; velocity, area, flow, and WSS in vessels feeding the AVMs and normal contralateral vessels were calculated using velocity data from the phase-contrast acquisition.
RESULTS: Patients with an asymptomatic presentation or mild symptoms (n = 4) had no significant difference in WSS in feeding vessels compared with normal contralateral vessels, whereas patients presenting with hemorrhage, severe headaches/seizures, or focal neurologic deficits (n = 6) had significantly higher WSS in feeding vessels compared with contralateral vessels.
CONCLUSIONS: In this study, we demonstrate that estimates of WSS and other hemodynamic parameters can be obtained noninvasively in patients with AVMs in clinically useful imaging times. Variation in WSS between feeders and normal vessels appears to relate to the clinical presentation of the patient. Further analysis of hemodynamic changes may improve characterization and staging of AVM patients, when combined with existing risk factors.

Entities:  

Mesh:

Year:  2012        PMID: 22499844      PMCID: PMC6278605          DOI: 10.3174/ajnr.A3010

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  37 in total

1.  Combined MR imaging and CFD simulation of flow in the human descending aorta.

Authors:  N B Wood; S J Weston; P J Kilner; A D Gosman; D N Firmin
Journal:  J Magn Reson Imaging       Date:  2001-05       Impact factor: 4.813

2.  Determinants of neurological outcome after surgery for brain arteriovenous malformation.

Authors:  A Hartmann; C Stapf; C Hofmeister; J P Mohr; R R Sciacca; B M Stein; A Faulstich; H Mast
Journal:  Stroke       Date:  2000-10       Impact factor: 7.914

3.  Hemodynamic shear stress and its role in atherosclerosis.

Authors:  A M Malek; S L Alper; S Izumo
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

4.  In vivo assessment and visualization of intracranial arterial hemodynamics with flow-sensitized 4D MR imaging at 3T.

Authors:  S Wetzel; S Meckel; A Frydrychowicz; L Bonati; E-W Radue; K Scheffler; J Hennig; M Markl
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

5.  Interleukin-6 involvement in brain arteriovenous malformations.

Authors:  Yongmei Chen; Ludmila Pawlikowska; Jianhua S Yao; Fanxia Shen; Wenwu Zhai; Achal S Achrol; Michael T Lawton; Pui-Yan Kwok; Guo-Yuan Yang; William L Young
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

6.  Endovascular treatment of intracranial arteriovenous malformations with onyx: technical aspects.

Authors:  W Weber; B Kis; R Siekmann; D Kuehne
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

7.  The ARUBA trial: current status, future hopes.

Authors:  J P Mohr; Alan J Moskowitz; Christian Stapf; Andreas Hartmann; Karen Lord; Steven M Marshall; Henning Mast; Ellen Moquete; Claudia Scala Moy; Michael Parides; John Pile-Spellman; Rustam Al-Shahi Salman; Alan Weinberg; William L Young; Alejandrina Estevez; Inam Kureshi; Jonathan L Brisman
Journal:  Stroke       Date:  2010-07-15       Impact factor: 7.914

8.  A proposed grading system for arteriovenous malformations.

Authors:  R F Spetzler; N A Martin
Journal:  J Neurosurg       Date:  1986-10       Impact factor: 5.115

9.  Complications following linear accelerator based stereotactic radiation for cerebral arteriovenous malformations.

Authors:  Jane Skjøth-Rasmussen; Henrik Roed; Lars Ohlhues; Bo Jespersen; Marianne Juhler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-09-30       Impact factor: 7.038

10.  Remodeling of the radial artery in response to a chronic increase in shear stress.

Authors:  X Girerd; G London; P Boutouyrie; J J Mourad; M Safar; S Laurent
Journal:  Hypertension       Date:  1996-03       Impact factor: 10.190

View more
  23 in total

1.  Combined DSA and 4D Flow Demonstrate Overt Alterations of Vascular Geometry and Hemodynamics in an Unusually Complex Cerebral AVM.

Authors:  C Wu; S Schnell; M Markl; S A Ansari
Journal:  Clin Neuroradiol       Date:  2015-10-16       Impact factor: 3.649

2.  Fast 4D flow MRI re-emerges as a potential clinical tool for neuroradiology.

Authors:  P Turski; M Edjlali; C Oppenheim
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-27       Impact factor: 3.825

3.  Interest of HYPR flow dynamic MRA for characterization of cerebral arteriovenous malformations: comparison with TRICKS MRA and catheter DSA.

Authors:  Raphaël Dautry; Myriam Edjlali; Pauline Roca; Cécile Rabrait; Yijing Wu; Kevin Johnson; Olivier Wieben; Denis Trystram; Christine Rodriguez-Régent; Fawaz Alshareef; Patrick Turski; Jean-François Meder; Olivier Naggara; Catherine Oppenheim
Journal:  Eur Radiol       Date:  2015-04-28       Impact factor: 5.315

Review 4.  Emerging techniques for evaluation of the hemodynamics of intracranial vascular pathology.

Authors:  Warren Chang; Melissa Huang; Aichi Chien
Journal:  Neuroradiol J       Date:  2015-02

5.  Evaluation of 4D vascular flow and tissue perfusion in cerebral arteriovenous malformations: influence of Spetzler-Martin grade, clinical presentation, and AVM risk factors.

Authors:  C Wu; S A Ansari; A R Honarmand; P Vakil; M C Hurley; B R Bendok; J Carr; T J Carroll; M Markl
Journal:  AJNR Am J Neuroradiol       Date:  2015-02-26       Impact factor: 3.825

6.  Optimal 4DFlow MR sequence parameters for the assessment of internal carotid artery stenosis: a simulation study.

Authors:  Myriam Edjlali; Catherine Oppenheim; Joseph Benzakoun; Pauline Roca; David Calvet; Olivier Naggara; Stéphanie Lion; Marie-Pierre Gobin-Metteil; Sylvain Charron; Victoria Cavero; Jean-François Meder
Journal:  Neuroradiology       Date:  2019-06-13       Impact factor: 2.804

7.  Intracranial artery velocity measurement using 4D PC MRI at 3 T: comparison with transcranial ultrasound techniques and 2D PC MRI.

Authors:  Stephan Meckel; Lorenz Leitner; Leo H Bonati; Francesco Santini; Tilman Schubert; Aurelien F Stalder; Philippe Lyrer; Michael Markl; Stephan G Wetzel
Journal:  Neuroradiology       Date:  2012-11-10       Impact factor: 2.804

8.  Quantitative evaluation of arteriovenous malformation hemodynamic changes after endovascular treatment using parametric color coding: A case series study.

Authors:  Rodrigo Rivera; Juan G Sordo; Daniel Echeverria; Lautaro Badilla; Camila Pinto; Catalina Merino-Osorio
Journal:  Interv Neuroradiol       Date:  2017-08-01       Impact factor: 1.610

9.  Influence of eddy current, Maxwell and gradient field corrections on 3D flow visualization of 3D CINE PC-MRI data.

Authors:  Ramona Lorenz; Jelena Bock; Jeff Snyder; Jan G Korvink; Bernd A Jung; Michael Markl
Journal:  Magn Reson Med       Date:  2013-09-04       Impact factor: 4.668

10.  Liquid Embolic Agents for Endovascular Embolization: Evaluation of an Established (Onyx) and a Novel (PHIL) Embolic Agent in an In Vitro AVM Model.

Authors:  D F Vollherbst; C M Sommer; C Ulfert; J Pfaff; M Bendszus; M A Möhlenbruch
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-18       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.